Ret proto-oncogene mutations in apparently sporadic Turkish medullary thyroid carcinoma patients: Turkmen study. 2005

M F Erdogan, and A Gürsoy, and G Ozgen, and M Cakir, and F Bayram, and R Ersoy, and E Algün, and B Cetinarslan, and A Cömlekçi, and P Kadioglu, and M K Balci, and I Yetkin, and T Kabalak, and G Erdogan
Department of Endocrinology and Metabolic Diseases, Ankara University School of Medicine, Turkey. murat.erdogan@temd.org.tr

OBJECTIVE Medullary thyroid carcinoma (MTC) frequently occurs in a sporadic form, but a substantial number of cases are hereditary and appear as part of the multiple endocrine neoplasia type 2 (MEN2) syndromes. Germline mutations in ret proto-oncogene have been shown to be the underlying cause of MEN2 syndromes. METHODS We carried out a multi-center study that aimed to perform mutational analysis of so called sporadic MTC patients. METHODS Fifty-six MTC patients verified by histopathologic examination were subjected to genetic analysis. Exon 10, 11, 13, 14, 15 and 16 of the ret gene were analyzed by DNA sequencing and restriction enzyme digestion method. RESULTS Among 56 apparently sporadic MTC patients, we identified 6 (10.7%) ret germline mutation carriers. Three individuals carried mutations at codon 634 in exon 11, one at codon 618 in exon 10, and two at codon 804 in exon 14. Identification of the predisposition gene mutation has allowed DNA-based strategy for direct mutation detection in patients with apparently sporadic MTCs. A substantial number of patients with apparently sporadic MTC carried germline mutations and 50% of their first degree relatives are expected to have or to develop MTC and/or other endocrine tumors. CONCLUSIONS These results indicate the importance of careful genetic surveillance of any patient with apparently sporadic MTCs.

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D010375 Pedigree The record of descent or ancestry, particularly of a particular condition or trait, indicating individual family members, their relationships, and their status with respect to the trait or condition. Family Tree,Genealogical Tree,Genealogic Tree,Genetic Identity,Identity, Genetic,Family Trees,Genealogic Trees,Genealogical Trees,Genetic Identities,Identities, Genetic,Tree, Family,Tree, Genealogic,Tree, Genealogical,Trees, Family,Trees, Genealogic,Trees, Genealogical
D005091 Exons The parts of a transcript of a split GENE remaining after the INTRONS are removed. They are spliced together to become a MESSENGER RNA or other functional RNA. Mini-Exon,Exon,Mini Exon,Mini-Exons
D005260 Female Females
D006579 Heterozygote An individual having different alleles at one or more loci regarding a specific character. Carriers, Genetic,Genetic Carriers,Carrier, Genetic,Genetic Carrier,Heterozygotes
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000090063 Proto-Oncogene Mas A protein that is encoded by the MAS1 gene. It is a receptor for ANGIOTENSIN 1-7 and acts as an antagonist of ANGIOTENSIN-2 TYPE 1 RECEPTOR. C-Mas Protein,II-Proto-Oncogene Proteins, Cellular,Mas Protein,Mas1 Protein,Proto-Oncogene Protein Mas,Proto-Oncogene Proteins C-Mas-1,C Mas Protein,C-Mas-1, Proto-Oncogene Proteins,Cellular II-Proto-Oncogene Proteins,II Proto Oncogene Proteins, Cellular,Mas, Proto-Oncogene,Protein Mas, Proto-Oncogene,Protein, C-Mas,Protein, Mas,Protein, Mas1,Proteins, Cellular II-Proto-Oncogene,Proto Oncogene Mas,Proto Oncogene Proteins C Mas 1
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D013964 Thyroid Neoplasms Tumors or cancer of the THYROID GLAND. Cancer of Thyroid,Thyroid Cancer,Cancer of the Thyroid,Neoplasms, Thyroid,Thyroid Adenoma,Thyroid Carcinoma,Adenoma, Thyroid,Adenomas, Thyroid,Cancer, Thyroid,Cancers, Thyroid,Carcinoma, Thyroid,Carcinomas, Thyroid,Neoplasm, Thyroid,Thyroid Adenomas,Thyroid Cancers,Thyroid Carcinomas,Thyroid Neoplasm

Related Publications

M F Erdogan, and A Gürsoy, and G Ozgen, and M Cakir, and F Bayram, and R Ersoy, and E Algün, and B Cetinarslan, and A Cömlekçi, and P Kadioglu, and M K Balci, and I Yetkin, and T Kabalak, and G Erdogan
October 1996, The Journal of clinical endocrinology and metabolism,
M F Erdogan, and A Gürsoy, and G Ozgen, and M Cakir, and F Bayram, and R Ersoy, and E Algün, and B Cetinarslan, and A Cömlekçi, and P Kadioglu, and M K Balci, and I Yetkin, and T Kabalak, and G Erdogan
November 2006, Journal of endocrinological investigation,
M F Erdogan, and A Gürsoy, and G Ozgen, and M Cakir, and F Bayram, and R Ersoy, and E Algün, and B Cetinarslan, and A Cömlekçi, and P Kadioglu, and M K Balci, and I Yetkin, and T Kabalak, and G Erdogan
July 1995, Clinical endocrinology,
M F Erdogan, and A Gürsoy, and G Ozgen, and M Cakir, and F Bayram, and R Ersoy, and E Algün, and B Cetinarslan, and A Cömlekçi, and P Kadioglu, and M K Balci, and I Yetkin, and T Kabalak, and G Erdogan
March 1996, Clinical endocrinology,
M F Erdogan, and A Gürsoy, and G Ozgen, and M Cakir, and F Bayram, and R Ersoy, and E Algün, and B Cetinarslan, and A Cömlekçi, and P Kadioglu, and M K Balci, and I Yetkin, and T Kabalak, and G Erdogan
February 1998, Molecular and cellular endocrinology,
M F Erdogan, and A Gürsoy, and G Ozgen, and M Cakir, and F Bayram, and R Ersoy, and E Algün, and B Cetinarslan, and A Cömlekçi, and P Kadioglu, and M K Balci, and I Yetkin, and T Kabalak, and G Erdogan
February 1997, Deutsche medizinische Wochenschrift (1946),
M F Erdogan, and A Gürsoy, and G Ozgen, and M Cakir, and F Bayram, and R Ersoy, and E Algün, and B Cetinarslan, and A Cömlekçi, and P Kadioglu, and M K Balci, and I Yetkin, and T Kabalak, and G Erdogan
January 2001, Wiadomosci lekarskie (Warsaw, Poland : 1960),
M F Erdogan, and A Gürsoy, and G Ozgen, and M Cakir, and F Bayram, and R Ersoy, and E Algün, and B Cetinarslan, and A Cömlekçi, and P Kadioglu, and M K Balci, and I Yetkin, and T Kabalak, and G Erdogan
October 1994, Human molecular genetics,
M F Erdogan, and A Gürsoy, and G Ozgen, and M Cakir, and F Bayram, and R Ersoy, and E Algün, and B Cetinarslan, and A Cömlekçi, and P Kadioglu, and M K Balci, and I Yetkin, and T Kabalak, and G Erdogan
August 1998, Journal of the Formosan Medical Association = Taiwan yi zhi,
M F Erdogan, and A Gürsoy, and G Ozgen, and M Cakir, and F Bayram, and R Ersoy, and E Algün, and B Cetinarslan, and A Cömlekçi, and P Kadioglu, and M K Balci, and I Yetkin, and T Kabalak, and G Erdogan
January 2007, Clinical laboratory,
Copied contents to your clipboard!